查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1449285

他克莫司市场、占有率、市场规模、趋势、行业分析报告：按产品类型、最终用途、按地区、按细分市场、预测，2024-203

Tacrolimus Market Share, Size, Trends, Industry Analysis Report, By Product Type (Injections, Tablets and Capsules, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 203
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2032年他克莫司市场规模将达到96.8326亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

器官移植率的提高正在推动他克莫司市场的成长。 他克莫司是一种强效免疫抑制剂，广泛用于移植患者，以防止新移植器官的排斥反应。 他克莫司市场的持续医学研究和药物进展为改善移植后患者的预后做出了重大贡献。 这些进展不仅提高了他克莫司的疗效，而且还导致了更具针对性和个性化的免疫抑制方法的发展。 他克莫司（一种用于预防移植后器官排斥的药物）的可用性和可及性的增加提高了器官移植率。 移植程序的简化和器官捐赠的宣传活动也促进了他克莫司市场的成长。

器官移植技术的进步正在推动他克莫司市场的成长。 微创移植技术的进步、器官保存方法的改进以及移植成功率的提高增加了对免疫抑制剂的需求。 他克莫司已成为移植医学中的重要药物，因为它比传统药物更有效且副作用更少。 随着手术技术和移植后护理的进步，他克莫司等免疫抑製药物的使用增加。 由于移植手术数量的增加以及移植作为治疗多种疾病的有效方法被广泛接受，对他克莫司的需求正在增加。

随着人口老化的加剧，对他克莫司等药物的需求也预计会增加。 这是因为老年人经常需要器官移植或面临免疫相关疾病。 医疗保健系统正在适应老龄化人口不断变化的医疗保健需求，为他克莫司製造商和供应商创造了巨大的市场机会。

他克莫司市场报告亮点

片剂和胶囊在 2023 年占最大的市场占有率，因为他克莫司更容易让患者服用并提高依从性。

由于器官移植手术数量的增加，免疫抑制剂将在2023年占市场主导地位。

由于器官移植的迅速增加以及该地区主要参与者的存在，北美在他克莫司市场上占主导地位。

目录

第1章简介

第 2 章执行摘要

第3章研究方法

第4章全球他克莫司市场洞察

  • 他克莫司市场 - 最终用途快照
  • 他克莫司市场动态
    • 推动者和机会
      • 研发活动的增加推动他克莫司市场成长
      • 自体免疫疾病盛行率的增加推动市场成长
    • 抑制因素和挑战
      • 不良反应和替代疗法的可用性阻碍了他克莫司市场的成长
  • PESTEL 分析
  • 他克莫司市场最终用途趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球他克莫司市场（依产品类型）

  • 主要发现
  • 简介
  • 注射
  • 片剂和胶囊
  • 其他

第 6 章全球他克莫司市场（按应用）

  • 主要发现
  • 简介
  • 皮肤炎
  • 免疫抑制
  • 其他

第 7 章全球他克莫司市场，依最终用途划分

  • 主要发现
  • 简介
  • 诊所
  • 医院
  • 其他

第 8 章按地区划分的全球他克莫司市场

  • 主要发现
  • 简介
    • 2019-2032 年他克莫司市场评估（按地区）
  • 他克莫司市场 - 北美
    • 北美：他克莫司市场，依产品类型，2019-2032 年
    • 北美：他克莫司市场，依最终用途，2019-2032 年
    • 北美：他克莫司市场，按应用划分，2019-2032 年
    • 他克莫司市场 - 美国
    • 他克莫司市场 - 加拿大
  • 他克莫司市场 - 欧洲
    • 欧洲：他克莫司市场，依产品类型，2019-2032 年
    • 欧洲：他克莫司市场，依最终用途，2019-2032 年
    • 欧洲：他克莫司市场，按应用划分，2019-2032 年
    • 他克莫司市场 - 英国
    • 他克莫司市场 - 法国
    • 他克莫司市场 - 德国
    • 他克莫司市场 - 义大利
    • 他克莫司市场 - 西班牙
    • 他克莫司市场 - 荷兰
    • 他克莫司市场 - 俄罗斯
  • 他克莫司市场 - 亚太地区
    • 亚太地区：他克莫司市场，依产品类型，2019-2032 年
    • 亚太地区：他克莫司市场，依最终用途，2019-2032 年
    • 亚太地区：他克莫司市场，依应用划分，2019-2032 年
    • 他克莫司市场 - 中国
    • 他克莫司市场 - 印度
    • 他克莫司市场 - 马来西亚
    • 他克莫司市场 - 日本
    • 他克莫司市场 - 印度尼西亚
    • 他克莫司市场－韩国
  • 他克莫司市场 - 中东和非洲
    • 中东和非洲：他克莫司市场，依产品类型，2019-2032 年
    • 中东和非洲：他克莫司市场，依最终用途分类，2019-2032 年
    • 中东和非洲：他克莫司市场，按应用划分，2019-2032 年
    • 他克莫司市场 - 沙乌地阿拉伯
    • 他克莫司市场 - 阿拉伯联合大公国
    • 他克莫司市场 - 以色列
    • 他克莫司市场 - 南非
  • 他克莫司市场 - 拉丁美洲
    • 拉丁美洲：他克莫司市场，依产品类型，2019-2032 年
    • 拉丁美洲：他克莫司市场，依最终用途，2019-2032 年
    • 拉丁美洲：他克莫司市场，按应用划分，2019-2032 年
    • 他克莫司市场 - 墨西哥
    • 他克莫司市场 - 巴西
    • 他克莫司市场 - 阿根廷

第9章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章公司简介

  • Astellas Pharma Inc
  • Biocon Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Inc
  • GlaxoSmithKline plc
  • LEO Pharma A/S
  • Novartis AG
  • Lupin Pharmaceuticals Inc.
  • Panacea Biotec
  • Pfizer Inc
Product Code: PM4519

The tacrolimus market size is expected to reach USD 9,683.26 million by 2032, according to a new study by Polaris Market Research. The report "Tacrolimus Market Share, Size, Trends, Industry Analysis Report, By Product Type (Injections, Tablets and Capsules, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing organ transplantation rates drive the tacrolimus market growth. Tacrolimus is a potent immunosuppressive drug extensively used in transplant patients to prevent the rejection of newly transplanted organs. The continuous advancements in medical research and pharmaceuticals within the tacrolimus market have significantly contributed to improving patient outcomes post-transplantation. These developments have not only enhanced the efficacy of tacrolimus but have also led to the development of more targeted and personalized approaches to immunosuppression. The increasing availability and accessibility of tacrolimus, a medication used to prevent organ rejection after transplantation, has led to a favorable increase in organ transplantation rates. Efforts to simplify transplantation procedures and educate the public on organ donation have also contributed to the tacrolimus market growth.

The advancements in organ transplantation procedures foster the tacrolimus market growth. The need for immunosuppressants has been on the rise due to advancements in minimally invasive transplant procedures, improved organ preservation methods, and higher success rates of transplants. Tacrolimus has emerged as a crucial medication in transplantation medicine because of its effectiveness and fewer side effects in comparison to traditional drugs. With advancements in surgical techniques and post-transplant care, the use of immunosuppressive drugs such as tacrolimus has increased. The demand for tacrolimus has increased due to the growing number of transplant surgeries and the wider acceptance of transplantation as an effective treatment for various medical conditions.

As the geriatric population grows, the demand for medications like tacrolimus is expected to increase. This is because older adults often require organ transplants or face immune-related disorders. Healthcare systems are adapting to meet the evolving healthcare needs of this aging demographic, creating a significant market opportunity for tacrolimus manufacturers and suppliers.

Tacrolimus Market Report Highlights

The tablets and capsules segment held the largest market share in 2023 due to tacrolimus being favorable and easy for patients to consume, ensuring better compliance with medication regimens.

The immunosuppression segment dominated the market in 2023 due to the rising number of organ transplant surgeries.

North America dominated the tacrolimus market, owing to the surge in organ transplants and the presence of the key players in the region.

The key market players include Astellas Pharma Inc., Biocon Ltd., Dr. Reddy's Laboratories Ltd., Glenmark Pharmaceuticals Inc., GlaxoSmithKline plc, LEO Pharma A/S, Novartis AG, Lupin Pharmaceuticals Inc., Panacea Biotec, and Pfizer Inc.

Polaris Market Research has segmented the tacrolimus market report based on product, application, end-use, and region:

Polypropylene Nonwoven Fabrics, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Injections
  • Tablets and Capsules
  • Others

Polypropylene Nonwoven Fabrics, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Dermatitis
  • Immunosuppression
  • Others

Polypropylene Nonwoven Fabrics, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Clinics
  • Hospitals
  • Others

Polypropylene Nonwoven Fabrics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1.Introduction

  • 1.1.Report Description
    • 1.1.1.Objectives of the Study
    • 1.1.2.Market Scope
    • 1.1.3.Assumptions
  • 1.2.Stakeholders

2.Executive Summary

  • 2.1.Market Highlights

3.Research Methodology

  • 3.1.Overview
    • 3.1.1.Data Mining
  • 3.2.Data Sources
    • 3.2.1.Primary Sources
    • 3.2.2.Secondary Sources

4.Global Tacrolimus Market Insights

  • 4.1.Tacrolimus Market - End-Use Snapshot
  • 4.2.Tacrolimus Market Dynamics
    • 4.2.1.Drivers and Opportunities
      • 4.2.1.1.Increasing research and development activities drive the tacrolimus market growth
      • 4.2.1.2.The increasing prevalence of autoimmune diseases facilitating the growth of the market
    • 4.2.2.Restraints and Challenges
      • 4.2.2.1.Side effects and the availability of the alternative treatments hampering on the tacrolimus market growth
  • 4.3.Porter's Five Forces Analysis
    • 4.3.1.Bargaining Power of Suppliers (Moderate)
    • 4.3.2.Threats of New Entrants: (Low)
    • 4.3.3.Bargaining Power of Buyers (Moderate)
    • 4.3.4.Threat of Substitute (Moderate)
    • 4.3.5.Rivalry among existing firms (High)
  • 4.4.PESTEL Analysis
  • 4.5.Tacrolimus Market End-Use Trends
  • 4.6.Value Chain Analysis
  • 4.7.COVID-19 Impact Analysis

5.Global Tacrolimus Market, by Product Type

  • 5.1.Key Findings
  • 5.2.Introduction
    • 5.2.1.Global Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • 5.3.Injections
    • 5.3.1.Global Tacrolimus Market, by Injections, by Region, 2019-2032 (USD Billion)
  • 5.4.Tablets and Capsules
    • 5.4.1.Global Tacrolimus Market, by Tablets and Capsules, by Region, 2019-2032 (USD Billion)
  • 5.5.Others
    • 5.5.1.Global Tacrolimus Market, by Others, by Region, 2019-2032 (USD Billion)

6.Global Tacrolimus Market, by Application

  • 6.1.Key Findings
  • 6.2.Introduction
    • 6.2.1.Global Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 6.3.Dermatitis
    • 6.3.1.Global Tacrolimus Market, by Dermatitis, by Region, 2019-2032 (USD Billion)
  • 6.4.Immunosuppression
    • 6.4.1.Global Tacrolimus Market, by Immunosuppression, by Region, 2019-2032 (USD Billion)
  • 6.5.Others
    • 6.5.1.Global Tacrolimus Market, by Others, by Region, 2019-2032 (USD Billion)

7.Global Tacrolimus Market, by End-Use

  • 7.1.Key Findings
  • 7.2.Introduction
    • 7.2.1.Global Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • 7.3.Clinics
    • 7.3.1.Global Tacrolimus Market, by Clinics, By Region, 2019-2032 (USD Billion)
  • 7.4.Hospitals
    • 7.4.1.Global Tacrolimus Market, by Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.5.Others
    • 7.5.1.Global Tacrolimus Market, by Others, By Region, 2019-2032 (USD Billion)

8.Global Tacrolimus Market, by Geography

  • 8.1.Key findings
  • 8.2.Introduction
    • 8.2.1.Tacrolimus Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3.Tacrolimus Market - North America
    • 8.3.1.North America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.2.North America: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.3.3.North America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4.Tacrolimus Market - U.S.
      • 8.3.4.1.U.S.: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.3.4.2.U.S.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.4.3.U.S.: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5.Tacrolimus Market - Canada
      • 8.3.5.1.Canada: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.3.5.2.Canada.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.5.3.Canada: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.4.Tacrolimus Market - Europe
    • 8.4.1.Europe: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.2.Europe.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.3.Europe: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4.Tacrolimus Market - UK
      • 8.4.4.1.UK: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.4.2.UK.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.4.3.UK: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5.Tacrolimus Market - France
      • 8.4.5.1.France: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.5.2.France.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.5.3.France: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6.Tacrolimus Market - Germany
      • 8.4.6.1.Germany: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.6.2.Germany.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.6.3.Germany: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7.Tacrolimus Market - Italy
      • 8.4.7.1.Italy: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.7.2.Italy.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.7.3.Italy: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8.Tacrolimus Market - Spain
      • 8.4.8.1.Spain: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.8.2.Spain.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.8.3.Spain: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9.Tacrolimus Market - Netherlands
      • 8.4.9.1.Netherlands: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.9.2.Netherlands.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.9.3.Netherlands: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10.Tacrolimus Market - Russia
      • 8.4.10.1.Russia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.10.2.Russia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.10.3.Russia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.5.Tacrolimus Market - Asia Pacific
    • 8.5.1.Asia Pacific: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.2.Asia Pacific.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.3.Asia Pacific: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4.Tacrolimus Market - China
      • 8.5.4.1.China: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.4.2.China.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.4.3.China: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5.Tacrolimus Market - India
      • 8.5.5.1.India: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.5.2.India.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.5.3.India: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6.Tacrolimus Market - Malaysia
      • 8.5.6.1.Malaysia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.6.2.Malaysia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.6.3.Malaysia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7.Tacrolimus Market - Japan
      • 8.5.7.1.Japan: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.7.2.Japan.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.7.3.Japan: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8.Tacrolimus Market - Indonesia
      • 8.5.8.1.Indonesia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.8.2.Indonesia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.8.3.Indonesia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9.Tacrolimus Market - South Korea
      • 8.5.9.1.South Korea: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.9.2.South Korea.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.9.3.South Korea: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.6.Tacrolimus Market - Middle East & Africa
    • 8.6.1.Middle East & Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.2.Middle East & Africa.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.6.3.Middle East & Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4.Tacrolimus Market - Saudi Arabia
      • 8.6.4.1.Saudi Arabia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.6.4.2.Saudi Arabia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.4.3.Saudi Arabia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5.Tacrolimus Market - UAE
      • 8.6.5.1.UAE: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.6.5.2.UAE.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.5.3.UAE: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6.Tacrolimus Market - Israel
      • 8.6.6.1.Israel: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.6.6.2.Israel.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.6.3.Israel: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7.Tacrolimus Market - South Africa
      • 8.6.7.1.South Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.6.7.2.South Africa.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.7.3.South Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.7.Tacrolimus Market - Latin America
    • 8.7.1.Latin America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.2.Latin America.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.7.3.Latin America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4.Tacrolimus Market - Mexico
      • 8.7.4.1.Mexico: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.7.4.2.Mexico.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.4.3.Mexico: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5.Tacrolimus Market - Brazil
      • 8.7.5.1.Brazil: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.7.5.2.Brazil.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.5.3.Brazil: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6.Tacrolimus Market - Argentina
      • 8.7.6.1.Argentina: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.7.6.2.Argentina.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.6.3.Argentina: Tacrolimus Market, by Application, 2019-2032 (USD Billion)

9.Competitive Landscape

  • 9.1.Expansion and Acquisition Analysis
    • 9.1.1.Expansion
    • 9.1.2.Acquisitions
  • 9.2.Partnerships/Collaborations/Agreements/Exhibitions

10.Company Profiles

  • 10.1.Astellas Pharma Inc
    • 10.1.1.Company Overview
    • 10.1.2.Financial Performance
    • 10.1.3.Product Benchmarking
    • 10.1.4.Recent Development
  • 10.2.Biocon Ltd.
    • 10.2.1.Company Overview
    • 10.2.2.Financial Performance
    • 10.2.3.Product Benchmarking
    • 10.2.4.Recent Development
  • 10.3.Dr. Reddy's Laboratories Ltd.
    • 10.3.1.Company Overview
    • 10.3.2.Financial Performance
    • 10.3.3.Product Benchmarking
    • 10.3.4.Recent Development
  • 10.4.Glenmark Pharmaceuticals Inc
    • 10.4.1.Company Overview
    • 10.4.2.Financial Performance
    • 10.4.3.Product Benchmarking
    • 10.4.4.Recent Development
  • 10.5.GlaxoSmithKline plc
    • 10.5.1.Company Overview
    • 10.5.2.Financial Performance
    • 10.5.3.Product Benchmarking
    • 10.5.4.Recent Development
  • 10.6.LEO Pharma A/S
    • 10.6.1.Company Overview
    • 10.6.2.Financial Performance
    • 10.6.3.Product Benchmarking
    • 10.6.4.Recent Development
  • 10.7.Novartis AG
    • 10.7.1.Company Overview
    • 10.7.2.Financial Performance
    • 10.7.3.Product Benchmarking
    • 10.7.4.Recent Development
  • 10.8.Lupin Pharmaceuticals Inc.
    • 10.8.1.Company Overview
    • 10.8.2.Financial Performance
    • 10.8.3.Product Benchmarking
    • 10.8.4.Recent Development
  • 10.9.Panacea Biotec
    • 10.9.1.Company Overview
    • 10.9.2.Financial Performance
    • 10.9.3.Product Benchmarking
    • 10.9.4.Recent Development
  • 10.10.Pfizer Inc
    • 10.10.1.Company Overview
    • 10.10.2.Financial Performance
    • 10.10.3.Product Benchmarking
    • 10.10.4.Recent Development

List of Tables

  • Table 1 Global Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 2 Global Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 4 Tacrolimus Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 6 North America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 14 Europe: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 17 UK: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 18 UK: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 20 France: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 21 France: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 41 China: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 42 China: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 44 India: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 45 India: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Tacrolimus Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Tacrolimus Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Product Type
  • Figure 9. Global Tacrolimus Market, by Product Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End-Use
  • Figure 11. Global Tacrolimus Market, by End-Use, 2022 & 2032 (USD Billion)
  • Figure 12. Tacrolimus Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Tacrolimus Market